BIXT · Bioxytran, Inc
$0.02
0.00 (-3.96%)
At close · Jul 30
Going-concern doubt
— flagged May 15, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These conditions raise substantial doubt about the Company’s ability to continue as a going concern. The financial statements do not include any adjustments relating to the recoverability and classification of recorded assets, or the amounts of and classification of liabilities that might be necessary in the event the Company cannot continue operations.”View the 10-Q filed May 15, 2026
Market Cap
$2.59M
Shares
114.20M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Mike Sheikh | Officer | Terminated | 2026-01-05 |
| Anders Utter | Chair of the Audit Committee | Resigned | 2025-12-15 |
| Anders Utter | Board of Directors | Resigned | 2025-12-15 |